Sigrima 420 Mg Injection
59000.0 INR/Vial
Product Details:
- Salt Composition Obinutuzumab 420 mg
- Dosage Form Parenteral
- Origin of Medicine Imported
- Pacakaging (Quantity Per Box) Single vial per box
- Indication Chronic Lymphocytic Leukemia, Non-Hodgkins Lymphoma, or as directed
- Drug Type General Medicines
- Ingredients Sigrima (active monoclonal antibody) 420 mg
- Click to View more
X
Sigrima 420 Mg Injection Price And Quantity
- 1 Vial
- 59000.0 INR/Vial
- Infusion reaction, neutropenia, fever, as per physician advice
- Clear to opalescent, colorless or slightly brown liquid
- Sigrima
- 24 months from date of manufacture
- Intravenous infusion
- Prescription
- For hospital use only. Do not self-administer.
- Schedule H Prescription Drug
Sigrima 420 Mg Injection Product Specifications
- General Medicines
- Obinutuzumab 420 mg
- Parenteral
- Liquid
- 1 vial Pieces
- Adults, as prescribed by the physician
- 420 mg as per physicians recommendation
- Single vial per box
- Administer as directed by healthcare professional
- Imported
- Chronic Lymphocytic Leukemia, Non-Hodgkins Lymphoma, or as directed
- Adults
- Sigrima (active monoclonal antibody) 420 mg
- Store in a cool, dry place at 2 C to 8 C. Do not freeze.
- Infusion reaction, neutropenia, fever, as per physician advice
- Clear to opalescent, colorless or slightly brown liquid
- Sigrima
- 24 months from date of manufacture
- Intravenous infusion
- Prescription
- For hospital use only. Do not self-administer.
- Schedule H Prescription Drug
Sigrima 420 Mg Injection Trade Information
- 100 Vial Per Month
- 7 Days
Product Description
Sigrima 420mg Injection is given as an injection into veins under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Hair loss, diarrhea, nausea, and fatigue are some common side effects of this medicine. This medicine may reduce the number of blood cells (decrease white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Specialized Oncology Immunotherapy
Sigrima 420 Mg Injection utilizes Obinutuzumab, a monoclonal antibody, to target and destroy cancerous cells in conditions like Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma. As an advanced immunotherapy agent, it is prescribed for adults and intended to be administered exclusively in a hospital environment.
Strict Administration and Storage Guidelines
This medication is formulated for intravenous infusion and must be delivered by healthcare professionals per physician guidance. Each vial must be stored at 2C to 8C, shielded from freezing, to maintain its efficacy and safety throughout its 24-month shelf life.
Optimal Patient Safety and Monitoring
Given its potent action, Sigrima 420 Mg Injection is for prescription use only (Schedule H) and should never be self-administered. Infusion reactions, neutropenia, and fever are potential side effects, thus patient monitoring during and after each treatment is essential.
FAQ's of Sigrima 420 Mg Injection:
Q: How is Sigrima 420 Mg Injection administered to patients?
A: Sigrima 420 Mg Injection is given as an intravenous infusion under the supervision of a healthcare professional, typically within a hospital setting to ensure patient safety.Q: What conditions can Sigrima 420 Mg Injection be used to treat?
A: This injection is indicated for adults with Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma, or as directed by a physician. Its immunotherapy action targets cancer cells in these conditions.Q: When should this medication be used, and who decides the dosage?
A: The medication is used as part of a treatment plan prescribed by a physician. The specific dosage and dosing schedule should always be determined by the healthcare provider based on the patient's clinical condition.Q: Where should Sigrima 420 Mg Injection be stored before use?
A: Store the vial in a cool, dry place, maintaining temperatures between 2C and 8C. It must not be frozen and should be kept out of reach of unauthorized individuals.Q: What process is involved in the preparation and infusion of Sigrima 420 Mg Injection?
A: The preparation and infusion are carried out by trained hospital staff, who reconstitute the injection as necessary and administer it intravenously while monitoring for any potential reactions.Q: What precautions should be taken while using Sigrima 420 Mg Injection?
A: This drug is for hospital use only and must never be self-administered. Patients are closely monitored for infusion reactions and other side effects, and any concerns should be immediately reported to the attending physician.Q: What are the key benefits of using Sigrima 420 Mg Injection?
A: Sigrima 420 Mg Injection targets cancer cells with precision, providing a beneficial treatment option in adult cancer therapy regimens, potentially improving outcomes for patients with specified forms of leukemia and lymphoma.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
